IL17A and myelodysplastic syndrome: The levels of Th17 and IL-17 in BM and peripheral blood in LR-MDS patients are significantly higher than those in HR-MDS and healthy control group, which stimulate a variety of cytokines to produce inflammatory reaction, and finally lead to increased apoptosis of BM cells and ineffective hematopoiesis (17, 27).